Navigation Links
Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
Date:1/13/2014

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today provided an update on the anticipated milestones for its product development programs in 2014.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"Halozyme is poised for a pivotal year in 2014," stated Dr. Helen Torley, President and Chief Executive Officer.  "With multiple collaboration products advancing to commercialization stage, our focus is now on advancing and unlocking the value of our three proprietary products, which are potentially game-changing for the company. There are a number of key development and commercialization events over the next twelve months that can be used to measure our progress."

"For PEGPH20, these include completion of enrollment of the Phase 2 pancreatic cancer study (Study 202) and initiation of a study to evaluate PEGPH20 in an additional tumor setting. With respect to our diabetes program, we plan to communicate results from the CONSISTENT 1 study of Hylenex® as a pre-treatment in patients with diabetes using insulin pumps in the first quarter of 2014. In support of maximizing the commercial potential of Hylenex as a pre-treatment in patients with diabetes using insulin pumps, in the coming weeks, we will be seeking input from the FDA regarding the path for a labeling update to include key efficacy and safety data prior to initiating promotion for this use. For HTI-501, we look forward to communicating top-line results from our cellulite trial also in the first quarter of 2014."

Proprietary Products

PEGPH20

  • Complete enrollment in the on-going Phase 2 multicenter, randomized clinical trial (Study 202) evaluating P
    '/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Secures Additional $20 Million Term Loan
2. Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics
3. Halozyme Therapeutics Announces Executive Transitions
4. Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference
5. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
6. Halozyme to Host Third Quarter 2013 Financial Results Conference Call
7. SWOG Initiates Randomized Phase 2 Clinical Trial of Halozymes PEGPH20 in Combination with modified FOLFIRINOX for Advanced Pancreatic Cancer
8. Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013
9. Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
10. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
11. Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  In line with CBME ... to the community with a charity program to create ... autism. CBME China team is coordinating ... and maternity manufacturers, brand owners and distributors. All donated ... July 2015. Proceeds from the sale will be used ...
(Date:5/5/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.22 per share will be paid ... as of the close of business on May 15, 2015.  ... Board of Directors and may be adjusted as business needs ...
(Date:5/5/2015)... 2015 GW Pharmaceuticals plc (Nasdaq: GWPH, ... company focused on discovering, developing and commercializing novel ... today the closing of the previously announced offering ... 1,600,000 American Depositary Shares (ADSs) at a price ... approximately $179.2 million (before deducting underwriting discount, commissions ...
Breaking Medicine Technology:CBME China Launches Charity Program to Support Children with Autism 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... MIAMI, Jan. 20, 2011 CyberKnife Center of ... Schwade, MD, FACR, FACRO, FASTRO, announces a presentation ... 38th Annual Caribbean Association of Neurosurgeon,s Annual Meeting, ... (Photo: http://photos.prnewswire.com/prnh/20110120/FL32893 ) ...
... 20, 2011 Cognizant (Nasdaq: ... business process outsourcing (BPO) services, announced that it has ... world,s leading innovation-driven pharmaceutical companies, to deliver an end-to-end ... marketing operations be more effective, efficient, and innovative. ...
Cached Medicine Technology:CyberKnife Center of Miami to Present at 38th Annual Caribbean Association of Neurosurgeon's Conference 2Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance 2Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance 3
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 Novodiax announced today that ... of Innovations with Ed Begley Jr., airing via ... times TBA. , This segment will explore Novodiax, ... diagnostics. Audiences will learn about Novodiax’s polymer detection ... behind the scenes to investigate how, based on ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Center ... GAP Funds has invested in e-Kare, Inc. of Fairfax, ... assessment and monitoring of chronic wounds. , Chronic wounds ... complex surgical wounds that affect over 6.5 million U.S. ... as a spin-off enterprise from the Children’s National Medical ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Stout Industries ... firefighter with El Paso and Austin, Texas fire departments. Stout ... . There are three main components to these fire safety ... remain constant when the power is turned on. They light ... to clearly see what is on the roof, preventing leg ...
Breaking Medicine News(10 mins):Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2
... cord injuries (SCI) is proving to help the human ... severed during this type of injury. In a review ... SCI published this month in the Springer journal ... from the Krembil Neuroscience Centre, Toronto Western Hospital in ...
... chance to ask local brain experts about the aging brain ... session on October 29 at Yale University. Part of a ... how to navigate the booming aging industry and factors that ... issues specific to the aging brain, such as changes in ...
... Gardner HealthDay Reporter , MONDAY, Oct. 17 ... years instead of every year have fewer false-positive results, ... being diagnosed with late-stage breast cancer, new research finds. ... risk of false-positives by about one-third and, over a ...
... the American Academy of Pediatrics (AAP) recommended all babies ... 1992, deaths from Sudden Infant Death Syndrome have declined ... entrapment and asphyxia, have increased. In an ... expanding its guidelines on safe sleep for babies, with ...
... make big improvements to the health of their populations ... health) by adopting a winning formula for strengthening health ... London School of Hygiene & Tropical Medicine. The research ... Kyrgyzstan, Tamil Nadu (India) and Thailand) that have achieved ...
... a decade of receiving mammograms, more than half of cancer-free ... because of false-positive results, and about one in 12 will ... every other year lowers a woman,s probability of having one ... 61 percent to 42 percent over the course of ...
Cached Medicine News:Health News:Timing for clinical trials for stem cell therapy in spinal cord injuries is right 2Health News:Staying Sharp in New Haven: Yale brain experts discuss successful aging at free forum 2Health News:Less Frequent Mammograms May Lower False-Positive Results 2Health News:Less Frequent Mammograms May Lower False-Positive Results 3Health News:AAP expands guidelines for infant sleep safety and SIDS risk reduction 2Health News:AAP expands guidelines for infant sleep safety and SIDS risk reduction 3Health News:'Good health at low cost' 25 years on - what makes a successful health system? 2Health News:'Good health at low cost' 25 years on - what makes a successful health system? 3Health News:High rate of false-positives with annual mammogram 2Health News:High rate of false-positives with annual mammogram 3
... System is an easy-to-use, workflow-based system designed to ... Inspirex consists of the SleepWorks software and either ... and durable systems can be used for a ... - including full EEG recording - and have ...
... Retrieval System is made up of three ... Microcatheter and the Merci Balloon Guide Catheter. ... the location of the clot has been ... Catheter is inserted through a small incision ...
... of care you can provide to your ... program, including innovative products, standardization and reimbursement ... pulsed lavage systems deliver the performance needed ... bacteria, and foreign material. Each provides controlled ...
The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono...
Medicine Products: